Kennedy Lewis, a private equity firm, completed the acquisitiion of Stimwave, a company which develops and markets wireless microsize injectable medical devices for neurology markets.Financial terms were not disclosed. “We are excited about the continued growth we have experienced over the last two years, during a challenging time. We are grateful for our customers’ partnership and the positive impact our therapy provides for their patients. The sale process we are undertaking will have an efficient and prompt exit, while we maintain our day-to-day commitment to meet our customers’ and patients’ support needs with the high standards of quality they expect from us," Aure Bruneau, Stimwave CEO.